[HTML][HTML] Correlation between pretreatment neutrophil-to-lymphocyte ratio and programmed death-ligand 1 expression as prognostic markers in non-small cell lung …
CF Pirlog, HT Cotan, A Parosanu, CO Slavu, AM Popa… - Cureus, 2022 - ncbi.nlm.nih.gov
Background The neutrophil-to-lymphocyte ratio (NLR) at baseline treatment is an important
marker of systemic inflammation, which is correlated with survival benefits in lung, breast …
marker of systemic inflammation, which is correlated with survival benefits in lung, breast …
[HTML][HTML] An immune-related nomogram model that predicts the overall survival of patients with lung adenocarcinoma
J Sun, Y Yan, Y Meng, Y Ma, T Du, T Yu… - BMC Pulmonary …, 2022 - Springer
Background Lung adenocarcinoma accounts for approximately 40% of all primary lung
cancers; however, the mortality rates remain high. Successfully predicting progression and …
cancers; however, the mortality rates remain high. Successfully predicting progression and …
[HTML][HTML] Clinicopathological Features and Status of Programmed Death Ligand-1 (PD-L1) Expression in Lung Cancer: A Single Centre Study From North India
F Ganie, N Mehfooz, F Siraj, UH Khan, S Mantoo… - Cureus, 2023 - ncbi.nlm.nih.gov
Methods This prospective, observational, cross-sectional study was done in a tertiary care
hospital in North India over 2 years from 2019 to 2021. A total of 100 patients diagnosed with …
hospital in North India over 2 years from 2019 to 2021. A total of 100 patients diagnosed with …
[PDF][PDF] Морфологічні та імуногістохімічні особливості нейроендокринних новоутворень легень
ГЄ Читаєва - 2023 - ir.librarynmu.com
Нейроендокринні новоутворення (НЕН)—гетерогенна група рідкісних пухлин, які
походять з клітин дифузної нейроендокринної системи різних органів і різняться за …
походять з клітин дифузної нейроендокринної системи різних органів і різняться за …
Evaluation of the programmed death-ligand 1 mRNA expression and immunopositivity and their correlation with survival outcomes in Indian lung cancer patients
S Kumar, M Pandey, IA Mir, A Mukhopadhyay… - Human Cell, 2022 - Springer
The presence of membranous immunopositivity of programmed death-ligand 1 (PD-L1) in
tumors serves as a key determinant of response to immune checkpoint inhibitors. However …
tumors serves as a key determinant of response to immune checkpoint inhibitors. However …
[PDF][PDF] Charakterisierung der Expression des Somatostatin-Rezeptors 4 in normalen und neoplastischen humanen Geweben mit Hilfe eines neuen monoklonalen …
B Ehms - 2022 - db-thueringen.de
Somatostatin (SS) ist ein zyklisches Peptidhormon, welches in seinen zwei bioaktiven
Formen SS-14 und SS-28 weit verbreitet im Körper vorkommt. Es vermittelt verschiedene …
Formen SS-14 und SS-28 weit verbreitet im Körper vorkommt. Es vermittelt verschiedene …
PD-L1 expression in bronchopulmonary neuroendocrine tumors: correlation with morphological features and prognosis
H Chytaieva, L Zakhartseva - 2021 - ir.librarynmu.com
The purpose of the study was to estimate the programmed death-ligand 1 (PD-L1)
expression in lung NETs (Grade 2 and Grade 3) and it's possible relation to …
expression in lung NETs (Grade 2 and Grade 3) and it's possible relation to …